본문 바로가기
bar_progress

Text Size

Close

【Expert Analysis】COVID-19 Pandemic, Should You Buy Stocks Related to 'Treatment Drugs'?

▶Stocks Related to ‘Novel Coronavirus’ Going Up Limit Again Today (Click)


The novel coronavirus, known as COVID-19, is causing fear as confirmed cases increase not only worldwide but also domestically.


In China, the number of infected people has already exceeded 70,000, and with confirmed cases surpassing 1,000 in Korea, concerns about a 'second MERS crisis' are growing.


▶Check Out Health-Related Stocks You Will 100% Regret Not Buying Now (Click)


With the spread of COVID-19, stock prices are rising sharply, especially for treatments and hygiene products.


Companies producing masks have hit the upper price limit as domestic confirmed cases continue to surge, and stocks related to AIDS and malaria treatments have also soared after it was revealed that these drugs have therapeutic effects against the novel coronavirus.


Antaeil Ahn, an expert at ITBC Stock specializing in bio and pharmaceutical fields, said, “As the number of domestic novel coronavirus infections increases, interest in treatments is also growing,” adding, “The key is to find the right buying point as research results related to treatments continue to emerge.”


▶Novel Coronavirus Spread! Check Out Rapidly Rising Stocks (Click)


Meanwhile, itbc Stock, a securities expert broadcast with 100,000 members, provides information on beneficiary stocks related to ‘novel coronavirus treatments’ through the link below.


▶Check Out Stocks Related to Novel Coronavirus Treatments Expected to Soar (Click)


Related stocks: Shinpung Pharmaceutical, Bodytech Med, Ringnet, Baekkwang Industry, Hanchang Paper


※ This content is unrelated to the editorial direction of Asia Economy, and all responsibility lies with the information provider.


© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Special Coverage


Join us on social!

Top